35.48
전일 마감가:
$36.21
열려 있는:
$36.51
하루 거래량:
626.63K
Relative Volume:
0.34
시가총액:
$4.57B
수익:
-
순이익/손실:
$-507.65M
주가수익비율:
-7.713
EPS:
-4.6
순현금흐름:
$-616.24M
1주 성능:
-2.12%
1개월 성능:
+8.34%
6개월 성능:
-59.61%
1년 성능:
-56.38%
백스사이트 Stock (PCVX) Company Profile
명칭
Vaxcyte Inc
전화
650-837-0111
주소
825 INDUSTRIAL ROAD, STE. 300, SAN CARLOS, CA
PCVX을(를) 다른 주식과 비교
주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
---|---|---|---|---|---|---|
![]()
PCVX
Vaxcyte Inc
|
35.43 | 4.69B | 0 | -507.65M | -616.24M | -4.60 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
458.63 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
545.71 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
320.92 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
565.44 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
291.14 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
백스사이트 Stock (PCVX) Upgrades & Downgrades
날짜 | 액션 | 분석자 | 등급 변경 |
---|---|---|---|
2025-04-22 | 개시 | Cantor Fitzgerald | Overweight |
2024-12-20 | 개시 | Goldman | Buy |
2023-12-07 | 개시 | Mizuho | Buy |
2023-04-18 | 개시 | TD Cowen | Outperform |
2023-01-03 | 재확인 | Needham | Buy |
2022-12-15 | 개시 | Guggenheim | Buy |
2022-11-17 | 개시 | BTIG Research | Buy |
2021-12-29 | 재개 | Jefferies | Buy |
2021-06-24 | 재개 | Jefferies | Buy |
2020-07-07 | 개시 | BofA Securities | Buy |
2020-07-07 | 개시 | Cantor Fitzgerald | Overweight |
2020-07-07 | 개시 | Needham | Buy |
모두보기
백스사이트 주식(PCVX)의 최신 뉴스
What drives Vaxcyte Inc. stock priceSpectacular growth rates - jammulinksnews.com
Is Vaxcyte Inc. a good long term investmentOverwhelming financial success - Autocar Professional
Vaxcyte Inc. Stock Analysis and ForecastExponential wealth increase - jammulinksnews.com
What analysts say about Vaxcyte Inc. stockSuperior risk-adjusted returns - jammulinksnews.com
Mizuho Maintains an Overweight Rating on Vaxcyte (PCVX) - MSN
Nisa Investment Advisors LLC Buys 293 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
How the (PCVX) price action is used to our Advantage - news.stocktradersdaily.com
Vaxcyte’s High-Stakes Bet On Next-Gen Pneumonia Vaccines - Finimize
What makes Vaxcyte Inc. stock price move sharplyBreakout Momentum Stocks - beatles.ru
Why Vaxcyte Inc. stock attracts strong analyst attentionBig Profit Small Risk Alerts - Newser
How Vaxcyte Inc. stock performs during market volatilityRisk Adjusted Stock Signals - Newser
Teacher Retirement System of Texas Sells 2,779 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - Defense World
Here’s Why Vaxcyte (PCVX) Sold Off in Q1 - Insider Monkey
(PCVX) Trading Advice - news.stocktradersdaily.com
Cantor Fitzgerald Maintains Overweight on Vaxcyte Amid Vaccine Development and ACIP Meeting - MSN
Vaxcyte (PCVX): Riding Passive Fund Winds to FDA Catalysts – A Tactical Play with Strategic Upside - AInvest
Vaxcyte, Inc.(NasdaqGS: PCVX) added to Russell 2500 Value Index - MarketScreener
Russell Reconstitution and Options Surge: Vaxcyte's Institutional Crossroads - AInvest
Vaxcyte Holds Annual Stockholders Meeting on Governance - TipRanks
How To Trade (PCVX) - news.stocktradersdaily.com
Cantor Fitzgerald Estimates Vaxcyte FY2026 Earnings - Defense World
Transcript : Vaxcyte, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 01 - MarketScreener
Vaxcyte: Sentiment Is Pushing The Shares Down (NASDAQ:PCVX) - Seeking Alpha
Cantor Fitzgerald maintains Overweight on Vaxcyte shares By Investing.com - Investing.com Canada
Vaxcyte, Inc. (NASDAQ:PCVX) Given Consensus Rating of “Buy” by Analysts - Defense World
(PCVX) Long Term Investment Analysis - news.stocktradersdaily.com
Head to Head Contrast: Vaxcyte (NASDAQ:PCVX) and Beam Therapeutics (NASDAQ:BEAM) - Defense World
Vaxcyte (VCYT) Jumps Over 4.5%: Is This Biotech Eyeing a Return Towards Its $121 High? - Daily Chhattisgarh News
Vaxcyte, Inc. (PCVX) Stock Analysis: Unpacking the 286% Potential Upside for Investors - DirectorsTalk Interviews
James T. Wassil ’99G ’05G of Vaxcyte Inc., Tells Graduates ‘The Journey Ahead is Yours to Shape’ - Lehigh University
Transcript : Vaxcyte, Inc. Presents at BofA Securities 2025 Healthcare Conference, May-13-2025 08 - marketscreener.com
Research Analysts Set Expectations for Vaxcyte Q3 Earnings - Defense World
Leerink Partnrs Brokers Cut Earnings Estimates for Vaxcyte - Defense World
백스사이트 (PCVX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):